Conclusions-MSI may have an important and early role in a subset of gastric cancers, particularly the intestinal type. The MSI-H subset of gastric cancer has features in common with its colorectal counterpart, whereas MSI-L and microsatellite stable cancers appear to develop through the loss of heterozygosity pathway. (J Clin Pathol 1999;52:504-508) 
Both colorectal 1 2 and gastric carcinomas 3 4 may show DNA microsatellite instability (MSI). In the case of colorectal cancer, MSI status is correlated with a range of clinical, pathological, and molecular variables. It is agreed that about 20% of colorectal cancers are MSI. Of these one half are MSI-high (MSI-H), in which instability is found in at least 40% of loci, and the remainder are MSI-low (MSI-L). [5] [6] [7] [8] Although a generic "suppressor" pathway for the molecular pathogenesis of colorectal cancer is well established, 9 MSI-H cancers are distinguished by a low frequency of mutation of the adenomatous polyposis coli (APC), K-ras, and p53 genes and infrequent loss of heterozygosity at 5q, 17p, and 18q. 5 Other genes including transforming growth factor type II receptor (TGF IIR), insulinlike growth factor receptor 2 (IGFR2), and BAX are associated with the "mutator" pathway. 8 Despite displaying a mild mutator phenotype, MSI-L colorectal cancers appear to evolve through the classical "suppressor" pathway. 5 8 Less is known of the molecular evolution of gastric cancer, though well diVerentiated or intestinal type gastric cancer share genetic profiles with colorectal cancer. 10 DiVerent genetic mechanisms apply to poorly diVerentiated or diVuse type carcinomas, for example loss of heterozygosity at 7q, cadherin mutation, or loss and amplification of K-sam and c-met. 10 MSI has been described in both well diVerentiated and poorly diVerentiated types of gastric cancer. Some reports have emphasised an association with poorly diVerentiated gastric cancer. 3 Others correlate MSI with intestinal metaplasia, adenoma, and intestinal-type or well diVerentiated gastric cancer. 11 12 These discrepancies relate, at least in part, to the need to distinguish MSI-H and MSI-L, as in colorectal cancer. 13 14 Early studies from Japan reported high frequencies of MSI in gastric cancer (39% and 33%), 3 4 but the incidence of MSI-H gastric cancer lies between 4% and 15%, similar to that of colorectal cancer. 12 15-18 There is also evidence that gastric MSI-H cancers share features with their colorectal counterparts, including infiltration by T lymphocytes and improved prognosis 19 and mutation of TGF RII. 20 21 It seems, however, that the MSI-L phenotype occurs with greater frequency in gastric than colorectal cancer. For example, using a panel of 138 microsatellite markers, Gleeson et al found MSI-L in 84% of cancers arising in the gastric cardia. 22 The aim of this preliminary study was to investigate the frequency of loss of heterozygosity at loci in 5q and 18q in a series of gastric cancers stratified as microsatellite stable (MSS), MSI-L, and MSI-H.
Methods
Fifty three gastric cancers and corresponding normal tissue were obtained from patients with surgically resected gastric carcinoma in Southwest Hospital, Chongqing, People's Republic China. Thirty nine men and fourteen women with an age range of 28 to 74 years were included (mean age of 53 years at diagnosis). In all cases, one half of each tissue sample was frozen in liquid nitrogen and stored at −80°C until analysed and the other half was submitted for histological examination. Fifteen of these specimens contained adjacent foci of intestinal metaplasia, which were also collected. DNA was extracted using standard protocols. Can-cers were classified as intestinal or diVuse according to Laurén. 23 Six well characterised loci in 5q, 17p, and 18q containing dinucleotide repeat sequences were studied. D5S409, D5S82, D17S261, D17S799, TCF-2, and D18S34 primers [24] [25] [26] [27] were used to amplify the repeat and short flanking sequences in template DNA using polymerase chain reaction (PCR). PCR was performed in 20 µl of reaction mixture containing 10 mmol/litre Tris-HCl (pH 8. , and 100 ng genomic DNA. The reaction was carried out in a thermal cycler at 94°C for 40 seconds, 55-62°C for 40 seconds, and 72°C for 40 seconds, for 35 cycles, with an initial denaturation step of 94°C for five minutes and a final extension step of 72°C for 10 minutes. Samples were then separated in 6% polyacrylamide, 7 M urea denaturing DNA sequencing gel, and visualised by autoradiography. The autoradiogram analysis of tumour and control patterns was carried out by two independent observers. Both observers had to identify band shifts in order to diagnose instability at a particular locus. A band shift was defined as the presence of bands in PCR products of sample tissue that were not visible in corresponding constitutional DNA.
The APC, mutated in colon cancer (MCC), and deleted in colon cancer (DCC) genes were investigated for loss of heterozygosity, and PCR was carried out as described by others. 28 29 The priming regions were located within the genes APC, MCC, and DCC at polymorphic sequences: an Rsa 1 RFLP in exon 11 of APC, a 14 base pair (bp) insertion/deletion polymorphism in exon 10 of MCC, and at Msp1 RFLP sites in VNTR, M2, and M3 of DCC. 28 29 The intragenic locations were selected to provide specific and sensitive evidence of loss. Annealing temperature, extension time, and the number of amplification cycles were optimised for each primer set. After amplification, PCR products were digested with appropriate restriction enzymes (for RFLP) or not (for variable numbers of tandem repeats) and electrophoresed on 3% agarose gels or 8% polyacrylamide gels, which were stained with ethidium bromide and photographed under ultraviolet light. Loss of heterozygosity was defined as a visible change in allele to allele ratio in the DNA relative to the ratio in corresponding normal DNA.
Analyses were carried out using the 2 test with Yates' correction. A p value of < 0.05 was considered significant.
Results
Seventeen of 53 gastric cancers (32.1%) showed evidence of MSI. Comparison of normal and tumour tissue DNA samples showed a shift in the latter, indicating an alteration in the microsatellite site (fig 1) . Based on the number of mutated MSI markers in each tumour, carcinomas were divided into three groups: MSI-H, showing MSI in three or more loci (7), MSI-L, showing MSI in one or two loci (10) , and microsatellite stable (MSS) (36) . 
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group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from Clinicopathological characteristics of MSI-H cases were compared with those of cases that were MSS or MSI-L (table 1 ). An association of MSI-H with intestinal histological type was found (p < 0.05), whereas no significant correlation was found between MSI-H and age at diagnosis, sex, tumour location, size, depth of invasion, or lymph node metastasis.
Three of 15 samples of intestinal metaplasia (20%) showed MSI at a single locus (MSI-L), as well as in the corresponding cancer tissue. This was seen only in cases of MSI-L cancers. Identical and possibly sequentially related micosatellite alterations were observed in the cancer tissue and adjacent intestinal metaplasia, two cases at locus D5S82 and the other case at D18S34.
Examples of loss of heterozygosity at APC and MCC are shown in fig 2. The loss of heterozygosity frequencies for APC, MCC, and DCC were 10 of 36 (27.8%), nine of 29 (31.0%), and 19 of 51 (37.3%) gastric cancers respectively. The associations of loss of heterozygosity and MSI status are shown in table 2. All tumours that showed loss of heterozygosity in APC, MCC, and DCC belonged to the MSS and MSI-low groups and none of the MSI-high tumours showed loss of heterozygosity. The numbers are too small to reach statistical significance, however.
Discussion
In this study 32.1% of 53 sporadic gastric cancers had MSI in at least one locus, a frequency falling within the wide reported range. 3 4 12 15-18 22 However, the frequency of MSI-H was only 13.7%, which is similar to figure reported by others in both gastric 12 15-18 and colorectal cancer. [5] [6] [7] [8] Gastric adenocarcinoma usually aVects patients older than 50 years and is uncommon in subjects younger than 40 years. Tumours occurring in young patients (under 40 years of age) account for less than 10% of all cases. 30 31 It has been suggested that early onset gastric carcinomas are more likely to have a genetic basis than those occurring in older patients. 30 32 Hayden et al investigated a series of 10 British gastric carcinoma patients aged 19 to 39 years using a panel of 12 microsatellite loci and found no evidence of MSI. 33 In the present study, we divided gastric cancers into two groups according to age and found no diVerence in MSI frequency in patients aged under 40 years and in those over 40 years. These results contrast with the situation in colorectal cancer in which 58% of patients without a family history of cancer aged under 35 years show evidence of MSI 32 and cast doubt on the role of the mutator phenotype as an important mechanism in the development of early onset gastric cancer.
Histologically, gastric cancer can be classified into two subtypes: intestinal and diVuse. 23 The former is often accompanied by widespread intestinal metaplasia in the vicinity of the tumour, and is generally believed to arise through a multistage process involving chronic gastritis and intestinal metaplasia. 34 These morphological changes from normal gastric epithelium may occur sequentially as a result of exogenous and endogenous factors that cause genetic alterations. 34 Some of these lesionsincluding p53 mutation and 17p, 5q, and 18q allelic loss, which are common in colorectal tumours-are more frequent in intestinal than in diVuse gastric carcinoma. 10 35 Previous observations also indicate that the MSI phenotype tends to be more frequent in tumours of intestinal than diVuse type. 11 12 36 These findings are in keeping with the suggestion that Interestingly, an identical and possibly sequential alteration was observed in the cancer samples and the adjacent metaplastic mucosa in three cases, supporting the concept of tumour development from intestinal metaplasia. This observation related to MSI-L cancers with a single mutated locus only. MSI was not detected in intestinal metaplasia surrounding MSI-H gastric cancers. The significance of low levels of MSI is currently unknown. The fact that the MSI-L phenotype in intestinal metaplasia implicated only D5S82 and D18S34 and occurred in adjacent intestinal type cancers in three instances suggests that these loci may serve as biomarkers for genetically unstable variants of intestinal metaplasia.
Attempts have been made to correlate the presence of MSI with other clinicopathological features in gastric carcinoma. Some have reported an association between MSI and expanding growth pattern, absent or minimal desmoplastic response, abundant lymphoid infiltration, low DNA content, relatively low frequency of lymph node metastasis, and improved prognosis. 19 37 Another study showed no survival advantage at five and eight years of follow up in patients stratified according to MSI status, even when corrected for stage distribution. 38 In the present study, we did not observe a correlation between MSI status and tumour location, size, depth of invasion, or lymph node metastasis, indicating a limited role for MSI in predicting prognosis of gastric cancer. However, further follow up of a larger number of patients is required.
None of the MSI-high tumours showed loss of heterozygosity at APC, MCC, and DCC loci, an observation that parallels studies in colorectal cancer 5 39 and suggests that MSI-H gastric tumours diVer from MSS and MSI-L tumours in their mode of molecular evolution. Again, the findings need to be confirmed in a larger series.
CONCLUSIONS
Genetic instability underlies the multistep evolution of gastric cancer. Gastric carcinomas can be classified three groups: MSS, MSI-L, and MSI-H. The MSI-H tumours appear to share features with their colorectal counterparts, exemplified in this study by the low frequency of loss of heterozygosity at 5q and 18q. Widespread MSI may play an important and early role in the evolution of a subset of intestinal type gastric carcinomas. The biological significance of MSI-L remains unclear.
This work was supported by the National Funds of Natural Science of China, No 39670347. We thank Lynne Reid for photographic assistance and Brenda Mason for secretarial support.
